Victory Capital Management Inc Enzon Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 04, 2020
BUY
$0.14 - $0.22 $43 - $67
309 Added 4.87%
6,653 $1,000
Q4 2019

Feb 04, 2020
BUY
$0.2 - $0.25 $1,268 - $1,586
6,344 New
6,344 $1,000

About ENZON PHARMACEUTICALS, INC.

ENZN Quotes by TradingView
  • Ticker ENZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 74,214,600
  • Market Cap $11.1M
  • Description
  • Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
More about ENZN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email